AstraZeneca's CFO, Aradhana Sarin, has denied that geopolitical tensions are impacting the company's operations in China. This follows reports that the pharma giant is considering spinning off its business in China to shield it from China's strained relationship with the US and Europe. Sarin stated that the company does not see geopolitics playing a role in doing business in China and highlighted the success and growth of the company's operations in the country. AstraZeneca's earnings for the second quarter showed revenue growth of 6%, with China revenues expanding by 7%.

The post AstraZeneca CFO Denies Geopolitics Impacts the company’s China business after spinoff rumors appeared first on Balanced News Summary.